Every quarter brings a fresh batch of Court of Appeal opinions that quietly rearrange the furniture in plaintiff personal-injury practice. The headline cycle runs on verdicts and MDLs, but the case work changes most when intermediate courts clarify foundation rules, evidentiary thresholds, and apportionment math. This digest pulls together the doctrinal threads worth watching as we close out the second quarter of 2026.
The pattern this season is unmistakable: defense teams keep pressing on biller foundation and economic-damage caps, while plaintiffs continue to find traction on premises duty, employer-owned vehicle theories, and Code of Civil Procedure section 998 cost-shifting. None of these areas is settled, and the panels are not aligned on every point. The practical takeaway is to read the new opinions against the older controlling authority before you commit to a trial theory or a motion in limine.
Medical Specials: Howell's Long Shadow Keeps Lengthening
Howell v. Hamilton Meats & Provisions, Inc. (2011) 52 Cal.4th 541 limited insured plaintiffs' recovery of past medical specials to amounts actually paid and accepted as payment in full. Corenbaum v. Lampkin (2013) 215 Cal.App.4th 1308 extended that holding to bar use of billed amounts as evidence of past or future medical damages or as a foundation for non-economic damages. Pebley v. Santa Clara Organics, LLC (2018) 22 Cal.App.5th 1266 carved out uninsured plaintiffs treating on a lien or out-of-pocket basis, letting full billed charges remain on the table.
Qaadir v. Figueroa (2021) 67 Cal.App.5th 790 added another layer: an uninsured plaintiff treating under a letter of protection or with a medical-finance lien can present billed charges, but the defense gets to cross-examine on the financial arrangement, including any downstream sale of the receivable at a discount. The current crop of opinions is pushing on exactly what foundation the defense must lay before that cross opens up — and on whether a treater can opine on reasonableness when the underlying account has been factored. For the practitioner, the rule of thumb is this: if you are working a lien-funded file, your letter-of-protection paper needs to be bulletproof before the deposition cycle starts, and your billing-custodian declaration needs to track the actual chargemaster, not a recreated summary.
Future Medicals and the Reasonable-Value Fight
Future medical damages remain the most contested line item in serious injury cases because Howell does not directly fix the ceiling. Plaintiff experts continue to anchor future cost on a reasonable-value analysis informed by past billing, while defense experts press CMS-rate or insurance-paid benchmarks. Recent appellate work has reinforced that the foundation question is whether the expert relied on data of a type reasonably relied on by experts in the field, not whether the data tracks a particular payer's allowable. Lay that foundation cleanly in the expert designation and the deposition, and the trial-court Sargon ruling tends to hold.
Duty, Foreseeability, and the Rowland Recalibration
Rowland v. Christian (1968) 69 Cal.2d 108 still controls the duty analysis, but the Supreme Court's Kuciemba v. Victory Woodworks, Inc. (2023) 14 Cal.5th 993 take-home COVID decision and the Brown v. USA Taekwondo (2021) 11 Cal.5th 204 special-relationship line keep feeding back into ordinary premises and security cases. Trial courts are sustaining demurrers on duty grounds where the connection between the defendant's conduct and the plaintiff's injury is judged too attenuated, and the appellate response has been mixed.
Where plaintiff counsel has been winning reversal is on the moral-blame and burden-on-the-community factors. Panels are reminding trial judges that the Rowland factors are weighed, not counted, and that the foreseeability prong asks about the general category of harm, not the precise mechanism. If you are briefing a duty motion this quarter, plead the foreseeable-category framing on the face of the complaint. Do not let the trial court collapse foreseeability into proximate cause at the pleading stage — that is the move the published reversals are correcting.
Apportionment, Settled Tortfeasors, and Proposition 51
Civil Code section 1431.2 still requires apportionment of non-economic damages by comparative fault, including to non-parties and settled tortfeasors. Two practical issues continue to generate published opinions: whether the defendant has carried its evidentiary burden to put a non-party on the verdict form, and how Howell-reduced economic damages interact with joint and several liability.
The cleaner rule is that the defendant who wants comparative fault apportioned to an absent actor has to put on substantial evidence of that actor's fault, not just argue empty-chair to the jury. On the economic-damages side, joint and several liability attaches to the post-Howell paid figure, not the billed amount, and there is no separate apportionment of those numbers under section 1431.2. Recent opinions have reinforced both points, and defense post-trial motions trying to relitigate apportionment math on JNOV are getting short shrift where the verdict form was drafted correctly.
Section 998 Offers, Costs, and Expert Witness Fees
Code of Civil Procedure section 998 remains one of the highest-value strategic tools in plaintiff practice and the most heavily litigated cost statute in California. Appellate panels keep reminding counsel that the offer must be unconditional, in writing, served with statutory acceptance language, and capable of valuation against the eventual judgment.
Two recurring fact patterns are drawing reversal. First, multi-defendant offers that do not specify how the joint offer is to be allocated, or that require all defendants to accept jointly, continue to be voided. Second, offers conditioned on dismissal with prejudice plus a general release that sweeps in unrelated potential claims have been struck as not in good faith. If your 998 fails on appeal, you lose expert fees that often run six figures in a serious orthopedic or traumatic-brain-injury workup. The discipline is to draft the offer the way the case will be tried: clean, defendant-specific, and tied to the pleaded claims.
A second 998 issue working its way through the appellate pipeline is whether mediator and arbitrator fees fall within recoverable costs after a beating of an offer. The statutory text and CRC framework give some textual support, but the panels are not uniform. Until the question is settled, segregate those fees in your memorandum of costs so the trial court can rule on them discretely without putting the rest of your bill at risk.
Liens, Subrogation, and the Recovery Side of the File
The lien side keeps generating appellate work because the underlying statutes have not kept pace with current healthcare finance. Civil Code sections 3045.1 through 3045.6 still govern hospital liens, but the courts are policing the procedural prerequisites tightly: timely notice, accurate amount, and proper recording. A lien that misses a statutory step is unenforceable, and the plaintiff has standing to challenge it through declaratory relief in the underlying action. Current hospital-lien practice requires you to demand the chargemaster basis on every claimed amount and to test whether the hospital actually treated the plaintiff within the statutory window.
On the public-payer side, the Ahlborn line continues to constrain Medi-Cal's recovery to the medical portion of the settlement. Plaintiff counsel who do not actively litigate the Ahlborn allocation are leaving meaningful client money on the table. ERISA self-funded plan reimbursement remains the hardest fight because U.S. Airways, Inc. v. McCutchen (2013) 569 U.S. 88 and Montanile v. Board of Trustees (2016) 577 U.S. 136 narrowed equitable defenses, but careful reading of the plan document — especially the funding designation and any allocation language — still produces meaningful reductions in the right case.
What This Means for Trial Strategy
None of these decisions individually moves the needle on a settlement conference. Read together, they are nudging plaintiff practice in two directions. The first is earlier and more careful documentation of the economic-damage foundation, because the defense bar is using every Howell-Corenbaum-Pebley wrinkle to keep billed charges out and to attack lien arrangements on cross. The second is sharper pleading on duty and foreseeability, because intermediate appellate panels are not going to rescue a vague Rowland analysis on demurrer review.
Calendar reminder for the practitioner: pull the slip opinions for your active matters, run them against the controlling authority you cited in your last motion, and update the briefs before the next law-and-motion cutoff. The doctrine moves quietly, and the cases that turn on it move loudly.